Transradial Technologies, Inc.

Solving the problems with current method to stop bleeding after radial artery (wrist) access post interventional procedures (i.e. stent delivery, angiogram)

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Syracuse, NY, USA
  • Currency USD
  • Founded January 2024
  • Employees 4
  • Incorporation Type C-corp
  • Website transradialtechnologies.com

Company Summary

Medical device company that has developed a novel transradial vascular closure device-designed to offer a “fast, safe, and easy-to-use” closure solution for radial artery punctures created during interventional procedures including cardiac catheterization and angiograms. The company has successfully conducted a clinical study that showed the device is effective at stopping bleeding, with no radial artery occlusions while reducing nurse time.

Team

  • Randy Hubbell

  • Ron Caputo, MD
    Chief Medical Officer

    Dr. Caputo is a practicing interventional cardiologist with over 80 authored/co-authored peer-reviewed publications and a history of successful medical device entrepreneurship, including co-founding Angiolink, Corp which was acquired by Medtronic (NYSE: MDT).

  • Steve Green
    President

    Steve has over 40 years of medical device design and development that includes over 20 US and Int’l patents and multiple regulatory product approvals.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free